Checkpoint Therapeutics, Inc. (CKPT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...

$CKPT insiders have traded $CKPT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales. We have seen 33 ...

Biotech, Inc. Fortress, a 10% owner of $CKPT, sold 100,000 shares of the company on 05-29-2025 for an estimated $129,000. We received data on the trade from a recent ...

Checkpoint Therapeutics (CKPT) has made some great progress lately with respect to its advancement of its drug known as cosibelimab. That is, it has already been able to file a Biologics Licensing ...

Short interest in Checkpoint Therapeutics Inc (NASDAQ:CKPT) decreased during the last reporting period, falling from 4.67M to 3.80M. This put 4.72% of the company's publicly available shares short.

Shares of Checkpoint Therapeutics (NASDAQ:CKPT) plunged 50% in morning trading Monday after the company said the FDA had declined to approve its drug cosibelimab for the treatment of advanced ...

Bridge Investment Group Holdings Inc. (NYSE: BRDG), relating to the proposed merger with Apollo. Under the terms of the agreement, Bridge stockholders and Bridge OpCo unitholders will receive 0.07081 ...

CKPT STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Checkpoint Therapeutics, Inc. (CKPT) Proposed Stockholder Buyout and Encourages Investors to Contact Philadelphia, Pennsylvania-- ...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.